Status:
UNKNOWN
Comparative Study of Minimally Invasive Surgical Approaches for Total Hip Arthroplasty
Lead Sponsor:
National and Kapodistrian University of Athens
Conditions:
Hip Osteoarthritis
Hip Arthropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Total hip arthroplasty is a method of choice for treating advanced osteoarthritis of the hip and one of the most frequent orthopedic procedures. Of all hip surgical approaches described, the tendency ...
Eligibility Criteria
Inclusion
- Patients that sign the Informed consent
- Patients aged 18 years and over who are going to undergo primary total hip arthroplasty
Exclusion
- I. Active infection II. Previous hip operation in any leg III. Any kind of operation the past 3 months IV. Obesity (BMI, Body Mass Index \>30) V. Autoimmune diseases or myositis of any etiology VI. Active cancer
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04311125
Start Date
April 1 2020
End Date
May 1 2022
Last Update
March 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
2nd Department of Orthopaedics
Athens, Attica, Greece, 14233